Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing high-protein and standard protein nutrition for critically ill patients at risk for refeeding syndrome

Official title: Comparing the Effects of High-protein Nutritional Support with Standard Protein Nutritional Support Through the Administration of Whey Protein Supplements on Clinical Outcomes of Critically Ill Patients At Risk for Refeeding Syndrome: a Randomized Comparative Clinical Trial

Run by Shahid Beheshti University · NCT06825377 · Data updated 2026-11-12

This study is testing whether giving critically ill patients more protein in their nutrition can help them recover better and avoid serious complications while in the ICU.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment150 (estimated)
SponsorShahid Beheshti University
Academic / other
Locations1 site (Tehran)
StatusRecruiting
StartedFebruary 13, 2025
Main results expectedFebruary 15, 2026
Study endsApril 15, 2026
Registry record updatedFebruary 14, 2025
Trial IDNCT06825377 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are critically ill patients aged 18 to 65 who are at risk for refeeding syndrome and can tolerate enteral nutrition.

Probably not a fit

Patients with active infections, severe organ failure, or those with specific conditions requiring different protein needs may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to identify the best protein administration strategy to improve nutritional and clinical outcomes while reducing complications and mortality in ICU patients at risk for refeeding syndrome. Participants will be randomly assigned to receive either high-protein or standard-protein nutritional support upon ICU admission. The study will monitor various health metrics, including multi-organ dysfunction syndrome and protein intake levels, over a 14-day intervention period. The primary hypothesis is that higher protein intake will lead to fewer cases of refeeding syndrome and better overall health outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved nutritional strategies that enhance recovery and reduce mortality in critically ill patients.

How similar studies have gone: While the approach of varying protein intake in critically ill patients is established, this specific comparison of high-protein versus standard protein nutritional support is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Willingness to cooperate and complete the informed consent form by the patient or legal guardian;
* age ≤ 18 years and \< 65 years;
* Non-pregnant and non-lactating;
* Serum creatinine ≥ 1.1 mg/dl for women and ≥ 1.2 mg/dl for men;
* No organ failure at the time of study enrollment;
* Intervention initiation within 48 hours of ICU admission;
* No history of metastatic cancer or end-stage disease;
* No absolute contraindications to enteral nutrition (e.g., persistent ileus, gastrointestinal ischemia, persistent or biliary vomiting, mechanical obstruction);
* No active infections, sepsis, severe sepsis, or septic shock;
* No intolerance to the whey protein supplement used in the current study;
* Not participating in other clinical trials concurrently with this study;
* No clinical conditions with higher or lower protein needs, such as burns, sepsis, cirrhosis, or chronic kidney disease;
* No diabetes with severe complications such as ketoacidosis, hyperosmolar coma, or acidosis.

Exclusion Criteria:

* Unwillingness to continue cooperation during study;
* Discharge or death of the patient earlier than 5 days from the start of the intervention;
* Occurrence of side effects during the study

Where it's running

  • Ayatollah Taleghani Medical, Educational, and Therapeutic Center, Shahid Beheshti University of Medical Sciences
    Tehran, Iran
    Recruiting

Study contacts

  • Principal investigator: Zahra Vahdat Shariatpanahi Professor — School of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences
  • Study coordinator: Zahra Vahdat Shariatpanahi Professor
  • Email: nutritiondata@yahoo.com
  • Phone: 0098-021-22357484

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.